Utah Medical Products, Inc. (UTMD)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 42 | 49 | 52 | 50 | 41 | 39 | 36 | - |
| Operating profit | $m | 11 | 10 | ||||||
| Net profit | $m | 11 | 15 | 16 | 17 | 14 | 11 | 10 | - |
| EPS reported | $ | 3.48 | 3.28 | ||||||
| Operating cashflow per share | $ | 4.53 | 3.29 | ||||||
| Capex per share | $ | 0.11 | 0.08 | ||||||
| FCF per share | $ | 4.42 | 3.20 | ||||||
| Free cash flow | $m | 14 | 11 | ||||||
| Net debt | $m | -86 | -88 | ||||||
| Book value equity | $m | 119 | 122 | ||||||
| Book value per share | $ | 36.81 | 38.33 | ||||||
| Number of shares | m | 3.24 | 3.18 | ||||||
| DPS (TTM paid) | $ | 1.22 | 1.24 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 16.08 | 22.62 | ||||||
| P/B LTM | x | 1.52 | 1.49 | ||||||
| P/S LTM | x | 4.71 | 5.02 | ||||||
| P/FCF LTM | x | 12.66 | 15.84 | ||||||
| EV/EBITDA LTM | x | 5.61 | 6.53 | ||||||
| EV/Sales LTM | x | 2.49 | 3.90 | ||||||
| Earnings Yield LTM | % | +6.22% | +4.42% | ||||||
| FCF Yield | % | +7.90% | +6.31% | ||||||
| Quality | |||||||||
| ROE | % | +9.46% | +8.74% | ||||||
| ROIC | % | +7.60% | +6.83% | ||||||
| Operating margin | % | +29.60% | +28.46% | ||||||
| Gross margin | % | +51.60% | +54.88% | ||||||
| FCF/Sales | % | +37.18% | +28.24% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -12.12% | -17.17% | ||||||
| Sales Growth YoY | % | -5.83% | -11.73% | ||||||
| Net Income Growth YoY | % | -18.65% | -24.42% | ||||||
| FCF Growth | % | -1.88% | -21.57% | ||||||
| Operating Profit Growth | % | -16.12% | -24.42% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +2.20% | +1.72% | ||||||
| Dividend Growth | % | +1.66% | +2.90% | ||||||
| Payout Ratio | % | +35.33% | +28.20% | ||||||
| FCF/Debt | x | 63.65 | 58.70 | ||||||
| Net Debt/EBITDA | x | -5.01 | -5.95 | ||||||
| EBIT/Net interest | x | 0.00 | 0.00 | ||||||
| Net debt/market cap | % | 0.00% | 0.00% | ||||||
| Net debt/Equity | x | -0.72 | -0.72 | ||||||
| Gross debt/equity | x | 0.00 | 0.00 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Utah Medical Products, Inc. (UTMD)
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free